The Collaborative Opportunity Fund provides seed grants to structural and HIV biologists to support collaborative projects and technology development to advance the field in our area of biological focus: (1) Evasion of anti-viral restriction factors and manipulation of degradation pathways by HIV and (2) hijacking of machineries for handling nucleic acids, with a particular focus upon interactions between HIV viral proteins and host molecules at early stages of the virus life cycle and an emphasis on the regulatory and accessory proteins Rev, Tat, Vif, Vpu, and Vpr and on PR.
We encourage the HIV community and also new and non-HIV investigators to apply. Applicants must be employed at an institution in the United States that is eligible to administer NIH funds.
The fund is now closed to applications. Please check back or join our mailing list to be notified of future funding opportunities.
Next Deadline: TBA
Funds available: Awards of up to $100,000 (total costs) will be made for one year, with a potential second year of funding to be awarded in a competitive renewal process.
Eligibility: Applications are open to any interested investigator at a qualified institution in the United States. Priority will be given to early-stage investigators who are either new to the HIV field or young investigators.
Contact HARC Program Manager, Melanie Brewer, with any inquiries.